AZN PDUFA decision: a positive outcome, -2.0%

On November 17, 2020, AstraZeneca PLC reached its PDUFA decision. The result was a positive outcome, and the stock moved -2.0% in the window around the event. It had already run +5.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.